Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 10Neoplasms 4Cancer Pain 3Pain, Postoperative 2Malignant Female Reproductive System Neoplasm 2Hematologic Neoplasms 2Emergencies 2Agnosia 2Tumor Surgery 1Rectal Neoplasms 1Pulmonary Nodule 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Intractable 1Neoplasm Metastasis 1Mucositis 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intraoperative Complications 1Ileus 1Duodenal Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Digestive System Diseases 1Constipation 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Hydromorphone × Clear all
NCT02461056 2015-06-03

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Samsung Medical Center

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡